Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News
SYS-CON.TV
Cloud Expo & Virtualization 2009 East
PLATINUM SPONSORS:
IBM
Smarter Business Solutions Through Dynamic Infrastructure
IBM
Smarter Insights: How the CIO Becomes a Hero Again
Microsoft
Windows Azure
GOLD SPONSORS:
Appsense
Why VDI?
CA
Maximizing the Business Value of Virtualization in Enterprise and Cloud Computing Environments
ExactTarget
Messaging in the Cloud - Email, SMS and Voice
Freedom OSS
Stairway to the Cloud
Sun
Sun's Incubation Platform: Helping Startups Serve the Enterprise
POWER PANELS:
Cloud Computing & Enterprise IT: Cost & Operational Benefits
How and Why is a Flexible IT Infrastructure the Key To the Future?
Click For 2008 West
Event Webcasts
Discriminatory Vaccine Policy Based on Falsified Paper

WASHINGTON, Nov. 17, 2012 /PRNewswire/ -- CoMeD -- As the Inspector General for Health and Human Services names vaccine researcher Poul Thorsen as one of its "Most Wanted" fugitives, the defense of mercury as 'safe in vaccines' seems to be crumbling.

In 2010, the Coalition for Mercury-free Drugs (CoMeD, Inc.) submitted an allegation to the Inspector General, that studies showing mercury-containing vaccines to be safe, are fraudulent. Now, a new "wanted" posted featuring Danish vaccine researcher Poul Thorsen, issued by the Inspector General  (HHS-OIG), offers proof this allegation is credible.

It is estimated that Poul Thorsen embezzled at least one million dollars of grant money from the CDC, while he co-authored, "Thimerosal and the occurrence of autism …".  CDC documents, obtained through FOIA, also show that Thorsen and his co-authors concealed the fact that autism declined in Denmark after Thimerosal was removed from the Danish vaccine program. 

Today, the US Government and the World Health Organization defend the ongoing use of Thimerosal, the highly toxic mercury-based vaccine preservative, based on a handful of industry-sponsored statistical studies, including Thorsen's. The manufacturer's Material Safety Data Sheet for Thimerosal, however, lists mental retardation as a possible outcome from exposure in utero and in children.  

Based on Thorsen's public conclusion, Dr. Jose Cordero, former US Assistant Surgeon General, declared that "(Thorsen's) Danish study…provide(s) one strong piece of evidence that Thimerosal is not causally linked to autism." Disturbingly, this study also helped the Institute of Medicine reach its 2004 declaration that mercury in vaccines is unrelated to the autism epidemic.

Globally, the proponents for Thimerosal-preserved vaccines are using this questionable research to justify providing mercury-preserved vaccines to developing countries.  While children in developed, western, nations receive mercury-free vaccine formulations, children in developing countries receive many mercury-preserved ones.

At the fourth meeting of the United Nations Intergovernmental Negotiating Committee (INC4) to write a global treaty on mercury, Rev. Lisa K. Sykes, President of CoMeD, Inc., termed this double standard in vaccine safety a form of discrimination based on economics and nationality.  It now seems this discrimination is also based upon falsified data and criminal conduct.

Despite this, the US National Institutes of Health and Centers for Disease Control and Prevention continue to collaborate with Poul Thorsen, using federal funds.  Thorsen remains in Denmark, and no date for his extradition has been made public.

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Cloud Developer Stories
Sematext is a globally distributed organization that builds innovative Cloud and On Premises solutions for performance monitoring, alerting and anomaly detection (SPM), log management and analytics (Logsene), and search analytics (SSA). We also provide Search and Big Data consult...
Cloud is not a commodity. And no matter what you call it, computing doesn’t come out of the sky. It comes from physical hardware inside brick and mortar facilities connected by hundreds of miles of networking cable. And no two clouds are built the same way. SoftLayer gives you ...
The speed of software changes in growing and large scale rapid-paced DevOps environments presents a challenge for continuous testing. Many organizations struggle to get this right. Practices that work for small scale continuous testing may not be sufficient as the requirements gr...
Modern Systems announced completion of a successful project with its new Rapid Program Modernization (eavRPMa"c) software. The eavRPMa"c technology architecturally transforms legacy applications, enabling faster feature development and reducing time-to-market for critical softwar...
In the midst of the widespread popularity and adoption of cloud computing, it seems like everything is being offered “as a Service” these days: Infrastructure? Check. Platform? You bet. Software? Absolutely. Toaster? It’s only a matter of time. With service providers positioning ...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021



SYS-CON Featured Whitepapers
ADS BY GOOGLE